Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Palatin Technologies, Inc. (PTN.F)

0.1842
+0.0044
+(2.45%)
At close: April 24 at 6:44:44 PM GMT+2
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
350
4,490.0900
4,853.6780
1,468.4570
-188.5970
Cost of Revenue
--
97.6370
418.4700
217.5290
147.8400
Gross Profit
350
4,392.4530
4,435.2080
1,250.9280
-336.4370
Operating Expense
30,744.7390
34,670.4180
37,921.4130
37,839.3760
30,263.4720
Operating Income
-30,394.7390
-30,277.9650
-33,486.2050
-36,588.4480
-30,599.9090
Net Non Operating Interest Income Expense
-14.3700
-17.1140
-20.0130
-29.6820
-23.4400
Other Income Expense
3,456.8980
558.9660
4,794.4780
419.8310
-2,973.1460
Pretax Income
-26,952.2110
-29,736.1130
-28,711.7400
-36,198.2990
-33,596.4950
Tax Provision
--
--
-4,674.9990
--
--
Net Income Common Stockholders
-26,952.2110
-29,736.1130
-24,036.7410
-36,198.2990
-33,596.4950
Diluted NI Available to Com Stockholders
-26,952.2110
-29,736.1130
-24,036.7410
-36,198.2990
-33,596.4950
Basic EPS
-1.54
-2.02
-2.21
-3.79
-3.50
Diluted EPS
-1.54
-2.02
-2.21
-3.79
-3.50
Basic Average Shares
18,249.9800
14,697.0960
10,890.1590
9,543.7620
9,466.0040
Diluted Average Shares
18,249.9800
14,697.0960
10,890.1590
9,543.7620
9,466.0040
Total Operating Income as Reported
-27,936.3770
-22,496.1210
-32,458.8830
-36,588.4480
-33,384.1010
Total Expenses
30,744.7390
34,768.0550
38,339.8830
38,056.9050
30,411.3120
Net Income from Continuing & Discontinued Operation
-26,952.2110
-29,736.1130
-24,036.7410
-36,198.2990
-33,596.4950
Normalized Income
-30,409.1090
-30,991.9910
-28,984.6466
-36,618.1300
-30,623.3490
Interest Expense
14.3700
17.1140
20.0130
29.6820
23.4400
Net Interest Income
-14.3700
-17.1140
-20.0130
-29.6820
-23.4400
EBIT
-26,937.8410
-29,718.9990
-28,691.7270
-36,168.6170
-33,573.0550
EBITDA
-26,618.2060
-29,379.9240
-28,403.3960
-36,041.9490
-33,521.9340
Reconciled Cost of Revenue
--
97.6370
418.4700
217.5290
147.8400
Reconciled Depreciation
319.6350
339.0750
288.3310
126.6680
51.1210
Net Income from Continuing Operation Net Minority Interest
-26,952.2110
-29,736.1130
-24,036.7410
-36,198.2990
-33,596.4950
Total Unusual Items Excluding Goodwill
3,456.8980
1,255.8780
5,910.2430
419.8310
-2,973.1460
Total Unusual Items
3,456.8980
1,255.8780
5,910.2430
419.8310
-2,973.1460
Normalized EBITDA
-30,075.1040
-30,635.8020
-34,313.6390
-36,461.7800
-30,548.7880
Tax Rate for Calcs
--
--
0.0002
--
--
Tax Effect of Unusual Items
--
--
962.3374
--
--
6/30/2021 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GYRE Gyre Therapeutics, Inc.
9.12
-0.76%
 
MBX MBX Biosciences, Inc.
9.27
+3.11%
 
NUVL Nuvalent, Inc.
73.98
+1.75%
 
TRML Tourmaline Bio, Inc.
17.32
-2.81%
 
ACLX Arcellx, Inc.
63.97
+0.53%
 
TECH Bio-Techne Corporation
50.78
+1.24%
 
GMAB Genmab A/S
20.54
+2.04%
 
IMNM Immunome, Inc.
8.52
+0.24%
 
TERN Terns Pharmaceuticals, Inc.
3.0500
+5.90%
 
BMRN BioMarin Pharmaceutical Inc.
62.74
+1.29%